ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022

The Alzheimer's disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver.

Devin Kepchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.